Brad D Maxwell (Brad Maxwell)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 8

Top Venues

Journal of labelled compounds & radiopharmaceuticals

Journal of medicinal chemistry

Nature reviews. Drug discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Rita Maria Concetta Di Martino, Brad D Maxwell, Tracey Pirali
Deuterium in drug discovery: progress, opportunities and challenges. Nature reviews. Drug discovery (2023)
Boris Czeskis, Charles S Elmore, Anthony Haight, David Hesk, Brad D Maxwell, Scott A Miller, Thomas Raglione, Klaas Schildknegt, John F Traverse, Peng Wang
Deuterated active pharmaceutical ingredients: A science-based proposal for synthesis, analysis, and control. Part 1: Framing the problem. Journal of labelled compounds & radiopharmaceuticals 62 (11) (2019)
Brad D Maxwell
New radical methods for the potential synthesis of carbon-13 and carbon-14 labeled complex products. Journal of labelled compounds & radiopharmaceuticals 61 (14) (2018)
Xiang-Yang Ye, Stephanie Y Chen, Shung Wu, David S Yoon, Haixia Wang, Zhenqiu Hong, Stephen P O'Connor, Jun Li, James J Li, Lawrence J Kennedy, Steven J Walker, Akbar Nayeem, Steven Sheriff, Daniel M Camac, Vidyhashankar Ramamurthy, Paul E Morin, Rachel Zebo, Joseph R Taylor, Nathan N Morgan, Randolph P Ponticiello, Thomas Harrity, Atsu Apedo, Rajasree Golla, Ramakrishna Seethala, Mengmeng Wang, Timothy W Harper, Bogdan G Sleczka, Bin He, Mark Kirby, David K Leahy, Jianqing Li, Ronald L Hanson, Zhiwei Guo, Yi-Xin Li, John D DiMarco, Raymond Scaringe, Brad D Maxwell, Frederick Moulin, Joel C Barrish, David A Gordon, Jeffrey A Robl
Discovery of Clinical Candidate 2-((2S,6S)-2-Phenyl-6-hydroxyadamantan-2-yl)-1-(3'-hydroxyazetidin-1-yl)ethanone [BMS-816336], an Orally Active Novel Selective 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor. Journal of medicinal chemistry 60 (12) (2017)
Donald J P Pinto, Michael J Orwat, Leon M Smith, Mimi L Quan, Patrick Y S Lam, Karen A Rossi, Atsu Apedo, Jeffrey M Bozarth, Yiming Wu, Joanna J Zheng, Baomin Xin, Nathalie Toussaint, Paul Stetsko, Olafur Gudmundsson, Brad D Maxwell, Earl J Crain, Pancras C Wong, Zhen Lou, Timothy W Harper, Silvi A Chacko, Joseph E Myers, Steven Sheriff, Huiping Zhang, Xiaoping Hou, Arvind Mathur, Dietmar A Seiffert, Ruth R Wexler, Joseph M Luettgen, William R Ewing
Discovery of a Parenteral Small Molecule Coagulation Factor XIa Inhibitor Clinical Candidate (BMS-962212). Journal of medicinal chemistry 60 (23) (2017)
Brad D Maxwell, Van Ly, Barry Brock, Robert Dodge, Mark Tirmenstein, Jacqueline Calvano
The synthesis of [14 C]4-acetylphenylalanine, effect on cell viability, and assessment of protein incorporation in male rat hepatocytes. Journal of labelled compounds & radiopharmaceuticals 60 (8) (2017)
Brad D Maxwell
The syntheses of [13 C6 ] and [phenyl-14 C(U)]BMS-816336, an inhibitor of 11β-hydroxysteroid dehydrogenase type 1, for type 2 diabetes. Journal of labelled compounds & radiopharmaceuticals 60 (8) (2017)
Elizabeth Anne Jurica, Ximao Wu, Kristin N Williams, Andres S Hernandez, David S Nirschl, Richard A Rampulla, Arvind Mathur, Min Zhou, Gary Cao, Chunshan Xie, Biji Jacob, Hong Cai, Tao Wang, Brian J Murphy, Heng Liu, Carrie Xu, Lori K Kunselman, Michael B Hicks, Qin Sun, Dora M Schnur, Doree F Sitkoff, Elizabeth A Dierks, Atsu Apedo, Douglas B Moore, Kimberly A Foster, Mary Ellen Cvijic, Reshma Panemangalore, Neil A Flynn, Brad D Maxwell, Yang Hong, Yuan Tian, Jason J Wilkes, Bradley A Zinker, Jean M Whaley, Joel C Barrish, Jeffrey A Robl, William R Ewing, Bruce A Ellsworth
Discovery of Pyrrolidine-Containing GPR40 Agonists: Stereochemistry Effects a Change in Binding Mode. Journal of medicinal chemistry 60 (4) (2017)

Brad D Maxwell.css-eqlu8i{font-size:small;padding-left:4px;} (Brad Maxwell)

Publication Activity (10 Years)

Top Topics

Top Venues

Brad D Maxwell (Brad Maxwell)